advertising
-
1
Garner SE, Eady A, Bennett C, et al: Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev 2012: 8, CD002086.
-
2
Warner AJ, Hathaway-Schrader JD, Lubker R, et al: Tetracyclines and bone: unclear actions with potentially lasting effects. Bone 159: 116377, 2022.
-
3
Eisen D, Hakim MD: Minocycline-induced pigmentation. Incidence, prevention and management. Drug Saf 18: 431, 1998.
-
4
Sánchez AR, Rogers RS III, Sheridan PJ: Tetracycline and other tetracycline-derivative staining of the teeth and oral cavity. Int J Dermatol 43: 709, 2004.
-
5
Dodd MA, Dole EJ, Troutman WG, et al: Minocycline-associated tooth staining. Ann Pharmacother 32: 887, 1998.
-
6
Filitis DC, Graber EM: Minocycline-induced hyperpigmentation involving the oral mucosa after short-term minocycline use. Cutis 92: 46, 2013.
-
7
Treister NS, Magalnick D, Woo S-B: Oral mucosal pigmentation secondary to minocycline therapy: report of two cases and a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97: 718, 2004.
-
8
Joseph WS, Sabo MA: Minocycline-induced cutaneous hyperpigmentation. JAPMA 90: 268, 2000.
-
9
Geria AN, Tajirian AL, Kihiczak G, et al: Minocycline-induced skin pigmentation: an update. Acta Dermatovenerol Croat 17: 123, 2009.
-
10
Katayama S, Ota M: Minocycline-induced hyperpigmentation. N Engl J Med 385: 2463, 2021.
-
11
Steadman W, Brown Z, Wall CJ: Minocycline black bone disease in arthroplasty: a systematic review. J Orthop Surg Res 16: 479, 2021.
-
12
Antonenko YN, Rokitskaya TI, Cooper AJL, et al: Minocycline chelates Ca2+, binds to membranes, and depolarizes mitochondria by formation of Ca2+-dependent ion channels. J Bioenerg Biomembr 42: 151, 2010.
-
13
Thiam D, Teo TY, Malhotra R, et al: Black bone disease in a healing fracture. BMJ Case Rep 2016: bcr2015211915, 2016.
-
14
Yang S, Takakubo Y, Kobayashi S, et al: Minocycline-induced periarticular black bones in inflamed joints which underwent arthroplastic reconstruction. Clin Orthop Surg 4: 181, 2012.
-
15
Kerbleski GJ, Hampton TT, Cornejo A: Black bone disease of the foot: a case study and review of literature demonstrating a correlation of long-term minocycline therapy and bone hyperpigmentation. J Foot Ankle Surg 52: 239, 2013.
-
16
Middleton SD, Anakwe RE, McKinley JC: Black bone disease of the foot. Minocycline related pigmentation. Foot Ankle Surg 17: e34, 2011.
-
17
Carter-Wale RL, Prior TD: Case study: an intraoperative finding of black bone disease in a podiatric surgery patient. Foot 29: 6, 2016.
-
18
Frost HM, Villanueva AR, Roth H, et al: Tetracycline bone labeling. J New Drugs 1: 206, 1961.
-
19
Milch RA, Rall DP, Tobie JE: Fluorescence of tetracycline antibiotics in bone. J Bone Joint Surg Am 40: 897, 1958.
-
20
Milch RA, Rall DP, Tobie JE: Bone localization of the tetracyclines. J Natl Cancer Inst 19: 87, 1957.
-
21
Dahners LE, Bos GD: Fluorescent tetracycline labeling as an aid to debridement of necrotic bone in the treatment of chronic osteomyelitis. J Orthop Trauma 16: 345, 2002.
-
22
Huang H, Zhao N, Li Q, et al. The therapeutic effectiveness using fluorescence-guided surgery for MRONJ. Biomed Res Int 2022: 1650790, 2022.
-
23
Muñoz-Mahamud E, Fernández-Valencia JÁ, Combalia A, et al: Fluorescent tetracycline bone labeling as an intraoperative tool to debride necrotic bone during septic hip revision: a preliminary case series. J Bone Jt Infect 6: 85, 2021.
Minocycline-Induced Black Bone Disease in Foot and Ankle Surgery: A Case Report
Search for other papers by Arij M. Rashid in
Current site
Google Scholar
PubMed
Search for other papers by Timothy P. Cheung in
Current site
Google Scholar
PubMed
Search for other papers by Rumzah Paracha in
Current site
Google Scholar
PubMed
Search for other papers by Glenn C. Vitale in
Current site
Google Scholar
PubMed
Search for other papers by Steven D. Vyce in
Current site
Google Scholar
PubMed
Background: Bone and periarticular tissue discoloration can be an unexpected finding that is often disconcerting for surgeons and may alter surgical plans and overall patient management. Common causes of bone discoloration include infection, avascular necrosis, and bone inflammation. Minocycline-induced black bone disease is a rare and relatively benign abnormality encountered in foot and ankle surgery that can cause significant black, blue, and gray discoloration of bone.
Methods: Unanticipated intraoperative findings of diffuse black, blue, and gray bone discoloration during an elective forefoot operation raised concern for a metabolically malignant process and prompted the conversion of plans for a first metatarsophalangeal joint implant arthroplasty to a Keller arthroplasty. The plan for proximal interphalangeal joint arthroplasties of the lesser digits were continued as planned. Bone specimens were sent for pathologic analysis.
Results: Postoperative analysis identified chronic use of a minocycline for acne vulgaris. Pathologic analysis of the specimens ruled out malignant processes. Altogether, the data available led to the diagnosis of minocycline-induced black bone disease. Since the last follow-up, the patient has healed well without complications.
Conclusions: Our case report underscores the importance of including the chronic use of tetracyclines in medical history intake during preoperative visits to assist the surgeon in intraoperative decision-making.
advertising
